Company Number: 14356717

Analysis Date: 2025-07-29 17:23 UTC

Financial Health Assessment: LIMALYA COMPLEX LIMITED

---

1. Financial Health Score: D

Explanation:
The company shows troubling signs of financial distress, primarily due to negative net assets and high liabilities, despite owning significant fixed assets. The negative shareholders' funds indicate that the company’s obligations exceed its assets, a symptom akin to a patient with a critical deficit in vital organ function. While the company is not currently insolvent in a legal sense, the financial structure is weak and demands close monitoring and intervention.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets (Tangible)	£804,244	Substantial asset base, primarily property. A strong "skeletal" structure.
Current Assets (Cash)	£314	Almost no liquid assets; extremely low "circulating blood" or cash flow.
Current Liabilities	£1,348	Small short-term debts, manageable but should be monitored.
Long-term Liabilities	£864,220	High debt load, significant "heart strain" on financial health.
Net Current Assets	-£1,034	Negative working capital, indicating difficulty covering short-term debts.
Net Assets (Equity)	-£61,010	Negative net worth, indicating liabilities exceed assets.
Shareholders' Funds	-£61,110	Equity deficit, a critical symptom of financial distress.
Profit and Loss Reserves	-£61,110	Accumulated losses; no retained earnings, indicating ongoing financial strain.

---

3. Diagnosis

• Asset-Heavy but Highly Leveraged: The company's main asset is a tangible fixed asset (likely property) valued at over £800k, acquired recently (during the 2024 financial year). However, this asset is financed largely through debt (£864k), creating a precarious capital structure. The debt-to-asset ratio exceeds 1, indicating over-leverage.

• Negative Equity: The shareholders' funds are negative by over £61k, meaning the company’s liabilities outweigh assets. This is a key indicator of financial distress and suggests potential solvency concerns if the situation persists.

• Poor Liquidity: With current assets barely covering current liabilities (£314 vs. £1,348), the company lacks healthy cash flow and working capital to meet short-term obligations comfortably. This symptom resembles a patient with poor circulation and low energy reserves.

• Dormant Filing Status with Emerging Activity: The company was dormant in prior years but appears to have commenced significant activity in the last financial year, purchasing a substantial fixed asset and incurring debt. This transition phase can be risky if not managed carefully.

• Single Director & Sole Owner: The company is controlled fully by one individual who also acts as the director, which simplifies decision-making but concentrates risk and responsibility.

---

4. Recommendations

1. Address Capital Structure:

   • Consider equity injection from the shareholder or new investors to shore up negative net assets.
   • Explore options to restructure or refinance long-term debt to reduce interest burdens and improve solvency.

2. Improve Liquidity:

   • Increase cash reserves to cover short-term liabilities comfortably.
   • Manage working capital tightly to avoid liquidity crises.

3. Asset Utilization:

   • Leverage the fixed asset (property) to generate revenue, e.g., through leasing or development, to improve cash flow.

4. Financial Monitoring:

   • Regularly monitor key financial metrics, especially liquidity ratios and gearing.
   • Prepare cash flow forecasts to anticipate funding needs.

5. Governance & Controls:

   • Given the sole ownership, consider periodic external financial review to provide independent oversight and risk assessment.

---

Medical Analogy Summary

The company’s financial health shows symptoms akin to a patient with a strong skeletal system (fixed assets) but critical circulatory issues (liquidity and negative equity). Without intervention to stabilize and strengthen its capital base and cash flow, the risk of financial failure increases.

---